Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Artrya Ltd logo — We are changing the way Coronary Heart Disease is diagnosed...

Artrya Ltd

We are changing the way Coronary Heart Disease is diagnosed and treated.

Founded 2018 Australia Australia 44 employees Series A Total: $15.00M AI, Biotechnology +2

General Information

Company Name Artrya Ltd
Founded Year 2018
Location Australia Australia
Employees 44
Industries AI, Biotechnology, Health Care +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Artrya Ltd. To contact Artrya Ltd, visit artrya.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Artrya Ltd compare?

A PDF of Artrya Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Artrya Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Artrya Ltd

Artrya is an applied artificial intelligence healthcare company that aims to revolutionize the diagnosis and treatment of Coronary Heart Disease. Founded in 2019 and headquartered in Australia, the company has garnered significant attention in the Biotechnology and Health Care industries. Artrya's recent Series A investment of $15.00M on 25 May 2021 brought onboard notable investors including Regal Funds Management, Washington H. Soul Pattinson, Watermark Funds Management, and Thorney Investment. The company's mission to collaboratively enhance coronary disease diagnosis with clinicians through deep learning algorithms showcases its commitment to predictive and preventive healthcare. Artrya's innovative approach, as reflected in their slogan "We are changing the way Coronary Heart Disease is diagnosed and treated," underscores the potential impact on patient care and industry advancements. With a focus on developing a comprehensive patient risk assessment, Artrya aims to address crucial gaps in existing healthcare systems.

Business keywords: coronary heart disease, diagnosis, treatment, deep learning algorithms, acute coronary events, prediction, prevention, diagnostic accuracy, medical services, ageing population, health system costs, patient risk assessment, clinical support

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $15.00M 4
Regal Funds Management Washington H. Soul Pattinson
Regal Funds Management, Washington H. Soul Pattinson +2
25 May 2021

Artrya Ltd Alternatives & Competitors

View All Alternatives
Artrya Ltd vs
Optellum
Optellum United Kingdom

Early lung cancer diagnosis with AI

Series A
49 employees
Health Care, Medical Devices
Compare Artrya Ltd vs Optellum
Artrya Ltd vs
Idoven
Idoven Spain

Re-defining the way cardiovascular diseases are detected and treated with Artificial Intelligence (A...

Venture round
63 employees
AI, Health Care
Compare Artrya Ltd vs Idoven
Artrya Ltd vs
Prolocor
Prolocor United States

Advancing patient care by empowering physicians with effective precision diagnostics for cardiovascu...

Convertible Note
8 employees
Biotechnology, Health Care
View all alternatives

FAQ About Artrya Ltd

We are changing the way Coronary Heart Disease is diagnosed and treated.
Artrya Ltd was founded in 2018.
Artrya Ltd is headquartered in Australia.
Artrya Ltd operates in AI, Biotechnology, Health Care and Machine Learning. Its work centres on coronary heart disease, diagnosis, treatment and deep learning algorithms.
Artrya Ltd has approximately 44 employees.
Artrya Ltd has completed 1 funding round, raising a total of $15.00M. The latest funding stage is Series A.
Top alternatives and competitors to Artrya Ltd include Optellum, Idoven, Prolocor, Cardio Intelligence Inc., Clinicgram. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Artrya Ltd and Optellum are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Artrya Ltd, https://bouncewatch.com/company/artrya, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout